FIELD: medicine.
SUBSTANCE: invention refers to medicine and may be used for tumour growth inhibition induction in experiment. For this purpose, the Pliss's lymphosarcoma cells 1 ml in the concentration of 20x106/ml proincubated for 30 min at 37°C with 100 mcl with a one-wall carbon nanotube suspension of the length of 100-200 nm functionalised by MH2-groups in the concentration of 10 mcg/ml. The tumour growth inhibition is specified as 97% for 20 days and prolonged life length is stated to increase in 1.68 times as compared to reference tumour carrier animals.
EFFECT: invention induces the tumour growth inhibition and prolongs life length of experimental animals ensured by the combined incubation of tumour cells and one-wall carbon nanotubes.
3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR INHIBITING PLISS LYMPHOSARCOMA GROWTH EXPERIMENTALLY | 2014 |
|
RU2561294C1 |
| METHOD FOR TUMOUR GROWTH INHIBITION IN EXPERIMENT | 2012 |
|
RU2506971C1 |
| METHOD OF PREVENTING TUMOUR GROWTH IN EXPERIMENT | 2011 |
|
RU2470377C1 |
| PREPARATION FOR INHIBITING TUMOR GROWTH AND METHOD FOR INHIBITING TUMOR GROWTH IN EXPERIMENT | 2006 |
|
RU2320334C1 |
| AGENT FOR TUMOR TISSUE DESTRUCTION AND CORRECTION OF ORGANISM WITH TUMOR ENDOGENOUS INTOXICATION AND METHOD FOR TUMOR TISSUE DESTRUCTION AND CORRECTION OF ORGANISM WITH TUMOR ENDOGENOUS INTOXICATION | 2006 |
|
RU2319486C1 |
| METHOD FOR SIMULATION OF TUMOR GROWTH DYNAMICS IN EXPERIMENT | 2019 |
|
RU2715891C1 |
| METHOD OF EXPERIMENTAL IMMUNE THERAPY OF TUMOURS | 2010 |
|
RU2463667C2 |
| METHOD OF EVALUATING NANODISPERSED COPPER ACTION ON TUMOUR GROWTH IN EXPERIMENT | 2009 |
|
RU2417453C1 |
| METHOD FOR ACHIEVING ANTIMETASTATIC EFFECT IN EXPERIMENT | 2017 |
|
RU2661704C1 |
| METHOD FOR MAKING TUMOR DISEASE PROPHYLAXIS UNDER EXPERIMENTAL CONDITIONS | 2004 |
|
RU2268070C2 |
